Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

This was the stock's second consecutive day of losses.

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...

Undeniably, Barchart’s screener for unusual stock options volume is an important tool for deciphering market sentiment, ...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23 ...

Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to buy. On June 10, the company announced that it is ...

Boston Scientific’s Operating Cash Flow (OCF) for the same period was $3.8 billion, indicating a good OCF margin of 21.7% compared to the S&P 500’s 14.9%.

However, that’s separate from Boston Scientific’s ongoing plans to build and grow into a wholly new Maple Grove site, with a $170 million, 400,000-square-foot project that the Star Tribune ...

Boston Scientific, one of the largest medical technology companies in the nation, is vacating its Minnetonka campus for good in one year, the listing said, opening up 24 acres for sale.